Royal Bank of Canada’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-251,680
| Closed | -$4.89M | – | 7036 |
|
|
2018
Q1 | $4.89M | Sell |
251,680
-15,219
| -6% | -$299K | ﹤0.01% | 2001 |
|
|
2017
Q4 | $4.44M | Sell |
266,899
-67,495
| -20% | -$1.24M | ﹤0.01% | 2141 |
|
|
2017
Q3 | $6.79M | Buy |
334,394
+15,911
| +5% | +$304K | ﹤0.01% | 1787 |
|
|
2017
Q2 | $5.13M | Sell |
318,483
-50,560
| -14% | -$747K | ﹤0.01% | 1926 |
|
|
2017
Q1 | $4.67M | Buy |
369,043
+8,075
| +2% | +$97.5K | ﹤0.01% | 1962 |
|
|
2016
Q4 | $4.78M | Sell |
360,968
-22,544
| -6% | -$385K | ﹤0.01% | 1980 |
|
|
2016
Q3 | $9.09M | Buy |
383,512
+6,187
| +2% | +$166K | 0.01% | 1539 |
|
|
2016
Q2 | $10.9M | Sell |
377,325
-178,049
| -32% | -$5.8M | 0.01% | 1403 |
|
|
2016
Q1 | $17.8M | Sell |
555,374
-21,011
| -4% | -$739K | 0.01% | 999 |
|
|
2015
Q4 | $24.6M | Buy |
576,385
+172,371
| +43% | +$6.89M | 0.02% | 819 |
|
|
2015
Q3 | $14.2M | Buy |
404,014
+301,794
| +295% | +$13.6M | 0.01% | 964 |
|
|
2015
Q2 | $4.69M | Buy |
102,220
+55,612
| +119% | +$2.64M | ﹤0.01% | 1658 |
|
|
2015
Q1 | $2.18M | Sell |
46,608
-12,024
| -21% | -$478K | ﹤0.01% | 2208 |
|
|
2014
Q4 | $1.86M | Buy |
58,632
+2,808
| +5% | +$82.2K | ﹤0.01% | 2396 |
|
|
2014
Q3 | $1.32M | Sell |
55,824
-9,907
| -15% | -$254K | ﹤0.01% | 2627 |
|
|
2014
Q2 | $1.97M | Sell |
65,731
-10,102
| -13% | -$273K | ﹤0.01% | 2307 |
|
|
2014
Q1 | $2M | Buy |
75,833
+46,161
| +156% | +$1.15M | ﹤0.01% | 2247 |
|
|
2013
Q4 | $746K | Buy |
29,672
+740
| +3% | +$16.5K | ﹤0.01% | 3090 |
|
|
2013
Q3 | $592K | Sell |
28,932
-966
| -3% | -$19.9K | ﹤0.01% | 3241 |
|
|
2013
Q2 | $597K | Buy |
+29,898
| New | +$531K | ﹤0.01% | 2995 |
|
Royal Bank of Canada's IPXL Position: Q2 2018 in Review
Royal Bank of Canada sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 251,680 shares — an estimated $4.89M sold.
Royal Bank of Canada first reported a position in IPXL in Q2 2013 and held it in 20 quarters. The position peaked at $24.6M in Q4 2015. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.
- Royal Bank of Canada reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
- Royal Bank of Canada sold 251,680 Impax Laboratories, Inc. shares in Q2 2018, an estimated $4.89M.
- Royal Bank of Canada first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 20 quarters.
- Royal Bank of Canada's Impax Laboratories, Inc. position peaked at $24.6M in Q4 2015.
- 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.
Based on Royal Bank of Canada's 13F filing for Q2 2018, filed 14 Aug 2018.